Coya Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COYA and other ETFs, options, and stocks.

About COYA

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

CEO

Arun Swaminathan

CEOArun Swaminathan

Employees

Employees8

Headquarters

Houston, Texas

HeadquartersHouston, Texas

Founded

2020

Founded2020

Employees

Employees8

COYA Key Statistics

Market cap

101.68M

Market cap101.68M

Price-Earnings ratio

-5.66

Price-Earnings ratio-5.66

Dividend yield

—

Dividend yield—

Average volume

75.78K

Average volume75.78K

High today

$6.19

High today$6.19

Low today

$5.95

Low today$5.95

Open price

$6.13

Open price$6.13

Volume

65.13K

Volume65.13K

52 Week high

$10.24

52 Week high$10.24

52 Week low

$4.65

52 Week low$4.65

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own COYA. This list is generated using Robinhood data, and it’s not a recommendation.

Coya Therapeutics

Why Robinhood?

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX. Show more

COYA Key Statistics

Analyst ratings

100%

People also own

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.